全球 DNA聚合酵素市场规模、份额、成长分析（按类型、按应用） - 产业预测，2024-2031 年

Global DNA Polymerase Market Size, Share, Growth Analysis, By Type(Taq Polymerase, Pfu Polymerase), By Application(Polymerase Chain Reaction, DNA Sequencing) - Industry Forecast 2024-2031

出版日期: 2024年03月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球DNA聚合酵素市场规模为1.326亿美元，预测期间（2024-2031年）复合年增长率为1.30%，从2023年的1.3432亿美元增加至2031年的1亿美元。预计将增长至4895万美元。

全球 DNA聚合酵素市场取得了显着成长，预计未来几年将进一步扩大。 DNA聚合酵素在生物技术、实验室、医学诊断和法医学等多个领域中发挥着至关重要的作用。推动市场成长轨迹的主要因素包括慢性病盛行率的增加、基因研究的进步以及对个人化医疗的需求不断增加。成长的主要驱动力之一是遗传性疾病和癌症、糖尿病和心血管疾病等慢性病的盛行率不断上升。随着这些疾病在全球范围内不断增加，DNA 复製、扩增和序列测定等任务对 DNA聚合酵素的需求也在增加。另一个主要的成长要素是快速成长的个人化医疗领域。 DNA聚合酵素有助于识别与特定疾病相关的遗传变异、突变和生物标记。这有助于针对个别患者标靶治疗和客製化治疗方法，从而改善临床结果。然而，全球DNA聚合酵素市场也面临挑战。一是DNA聚合酵素的高成本，尤其是高保真、专门的酵素。这些酵素的高成本限制了它们的可用性，特别是在预算紧张的小型实验室和医疗机构中。此外，市场竞争激烈，许多公司提供各种 DNA聚合酵素产品。这加剧了市场参与企业之间的竞争，导致价格压力，并使小公司难以获得重要的市场占有率。此外，严格的监管要求给市场参与者带来了障碍，特别是在医疗诊断和治疗应用方面。遵守监管标准并获得必要的核准既耗时又昂贵，使情况更加复杂。儘管有这些挑战，全球 DNA聚合酵素市场仍有望保持成长轨迹。技术进步、研发投资的增加以及 DNA聚合酵素应用的扩大预计将在短期内推动市场成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Thermo Fisher Scientific Inc.-United States
Merck KGaA-Germany
New England Biolabs-United States
Promega Corporation-United States
Agilent Technologies Inc.-United States
Illumina, Inc.-United States
QIAGEN NV-Netherlands
Takara Bio Inc.-Japan
Bio-Rad Laboratories, Inc.-United States
F. Hoffmann-La Roche Ltd.-Switzerland
Sigma-Aldrich Corporation（now part of Merck KGaA）-United States
LGC Limited-United Kingdom
Enzo Biochem, Inc.-United States
Lucigen Corporation-United States
Bioline GmbH（a Meridian Bioscience Company）-Germany
Toyobo Co., Ltd.-Japan
Genesee Scientific Corporation-United States
Vazyme Biotech Co., Ltd.-China
Takara Bio USA Holdings, Inc.-United States
Jena Bioscience GmbH-Germany

简介目录

Product Code: SQMIG35H2206

Global DNA Polymerase Market size was valued at USD 132.6 million in 2022 and is poised to grow from USD 134.32 million in 2023 to USD 148.95 million by 2031, at a CAGR of 1.30% during the forecast period (2024-2031).

The global DNA polymerase market is experiencing notable growth and is anticipated to further expand in the forthcoming years. DNA polymerases play a pivotal role across various domains, encompassing biotechnology, research laboratories, medical diagnostics, and forensics. The market's upward trajectory is chiefly propelled by several factors, including the escalating prevalence of chronic diseases, advancements in genetic research, and the growing demand for personalized medicine. One of the primary drivers of growth is the increasing incidence of genetic disorders and chronic ailments such as cancer, diabetes, and cardiovascular diseases. As these conditions continue to rise globally, the demand for DNA polymerases for tasks like DNA replication, amplification, and sequencing also escalates. Another significant growth catalyst is the burgeoning field of personalized medicine. DNA polymerases are instrumental in identifying genetic variations, mutations, and biomarkers linked to specific diseases. This facilitates targeted therapies and customized treatment regimens for individual patients, resulting in enhanced clinical outcomes. Nevertheless, the global DNA polymerase market encounters certain challenges. One such obstacle is the high cost associated with DNA polymerases, particularly high-fidelity and specialized enzymes. The expense of these enzymes may restrict their accessibility, especially for smaller research laboratories and medical facilities operating with limited budgets. Moreover, the market is highly competitive, with numerous players offering a diverse array of DNA polymerase products. This intensifies competition among market participants, leading to pricing pressures and making it difficult for smaller entities to gain significant market share. Additionally, stringent regulatory requirements, particularly in medical diagnostics and therapeutic applications, pose hurdles for market players. Compliance with regulatory standards and securing necessary approvals can be time-consuming and costly, further complicating the landscape. Despite these challenges, the global DNA polymerase market is poised to sustain its growth trajectory. Technological advancements, heightened investments in research and development activities, and the expanding applications of DNA polymerases are anticipated to propel market growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the global DNA polymerase market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global DNA Polymerase Market Segmental Analysis

Global DNA polymerase market is segmented based on type, application, and region. By type, the market is segmented into taq polymerase, pfu polymerase, and proprietary enzyme blends. By application, the market is segmented into polymerase chain reaction, DNA sequencing, DNA cloning, SNP analysis, next generation sequencing. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global DNA Polymerase Market

The surge in chronic diseases such as cancer and cardiovascular ailments has spurred an increased demand for diagnostic and treatment technologies. Consequently, in the post-COVID era, there has been a notable rise in the requirement for DNA polymerase, which plays a pivotal role in the amplification process of PCR (Polymerase Chain Reaction). Specifically, the treatment of cancer has witnessed heightened utilization of high-fidelity DNA polymerases. This has underscored the necessity for an advanced DNA polymerase capable of accurately replicating DNA and detecting mutations with a high degree of sensitivity and specificity. As a result, there has been a development of new DNA polymerase products with enhanced fidelity, speed, and overall performance. Moreover, specialized polymerases adept at amplifying and identifying DNA sequences associated with various diseases have also been introduced to the market.

Restraints in the Global DNA Polymerase Market

The rising cost of DNA polymerases presents a significant hurdle to the growth of the DNA polymerase market, hindering the adoption of innovative technologies that depend on costly enzymes. The developments in biotechnology have significantly impacted the pricing of DNA polymerases, leading to a steep increase in their costs. Consequently, some research laboratories or medical facilities may encounter challenges in affording these expensive polymerases.

Market Trends of the Global DNA Polymerase Market

With the increasing prominence of precision medicine, DNA polymerases are being employed to pinpoint specific genetic variations and mutations linked to diseases. This facilitates the creation of personalized treatments and therapies tailored to individual patients, thereby enhancing clinical outcomes.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global DNA Polymerase Market by Type

Market Overview
Taq Polymerase
Pfu Polymerase
and Proprietary Enzyme Blends

Global DNA Polymerase Market by Application

Market Overview
Polymerase Chain Reaction
DNA Sequencing
DNA Cloning
SNP Analysis
and Next Generation Sequencing

Global DNA Polymerase Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. - Netherlands
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation (now part of Merck KGaA) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lucigen Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioline GmbH (a Meridian Bioscience Company) - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toyobo Co., Ltd. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genesee Scientific Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vazyme Biotech Co., Ltd. - China
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio USA Holdings, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jena Bioscience GmbH - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments